Chemomab Therapeutics (CMMB) Total Liabilities (2011 - 2026)
Chemomab Therapeutics (CMMB) posted Total Liabilities of $1.55 million for Q2 2026, up 8.6% from $1.43 million a year earlier and up 39.5% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Total Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics' Total Liabilities came in at $1.48 million, down 56.9% from FY2024.
- Annual Total Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -2.5% (FY2020 to FY2025).
- In prior years, Chemomab Therapeutics' Total Liabilities was $3.43 million in FY2024 (-33.5%), $5.15 million in FY2023 (-24.6%), $6.84 million in FY2022 (+136.9%) and $2.89 million in FY2021 (+72.5%).
- The Q2 2026 figure stands as the highest quarterly Total Liabilities since Q1 2025.
- On a year-over-year basis, Total Liabilities increased in 1 of the last eight quarters, with an average decline of 42.8%.
- The strongest year-over-year quarter for Total Liabilities in the past five years was Q3 2022, with growth of 190.2%; the weakest was Q3 2025, with a decline of 75.2%.
- According to Business Quant data, Total Liabilities for the three prior quarters was $1.11 million (Q1 2026), $1.48 million (Q4 2025) and $1.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.80 Bn | 1,100.39 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 614.01 Bn | 532.53 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 503.59 Bn | 476.70 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 297.81 Bn | 261.80 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 261.50 Bn | 235.19 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 236.24 Bn | 191.64 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Chemomab Therapeutics | 7.65 Mn | -27.50 Mn | - | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Dec 31, 2024 | 3.43 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 4.68 Mn |
| Dec 31, 2023 | 5.15 Mn |
| Sep 30, 2023 | 5.38 Mn |
| Jun 30, 2023 | 6.86 Mn |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 6.84 Mn |
| Sep 30, 2022 | 5.60 Mn |
| Jun 30, 2022 | 4.54 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 1.93 Mn |
API Access
Chemomab Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();